97037 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants; Immunoglobulin superfamily B7 molecules, e.g. CD80, CD86
CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE
#302Oncolytic viral delivery of therapeutic polypeptides
#303Isolated peptides derived from the B7 ligand dimer interface and uses thereof
#304T-cell modulatory multimeric polypeptides and methods of use thereof
#305PD-L1 expressing hematopoietic stem cells and uses
#306Compositions and methods for targeted immunomodulatory antibodies and fusion proteins
#307CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE
#308Compositions and methods for treating cancer with anti-ROR1 immunotherapy
#309COLLAGEN-LOCALIZED IMMUNOMODULATORY MOLECULES AND METHODS THEREOF
#310Agents that modulate immune cell activation and methods of use thereof
#311Anti-PD-L1 antibodies
#312PD-L1 expressing hematopoietic stem cells and uses
#313Universal donor cells
#314UNIVERSAL DONOR CELLS
#315B7-RELATED NUCLEIC ACIDS AND POLYPEPTIDES USEFUL FOR IMMUNOMODULATION
#316Exosome for stimulating T cell and pharmaceutical use thereof
#317CAR T therapy through uses of co-stimulation
#318Compositions and methods for enhancing the stability of transgenes in poxviruses
#319Targeted TGFβ inhibition
#320MRNA combination therapy for the treatment of cancer
#321SECRETABLE VARIANT IMMUNOMODULATORY PROTEINS AND ENGINEERED CELL THERAPY
#322NEW PDL2 COMPOUNDS
#323Isolated B7-H4 specific compositions and methods of use thereof
#324Genetically modified non-human animal with human or chimeric PD-L1
#325CHIMERIC ANTIGEN RECEPTORS AND COMPOSITIONS AND METHODS OF USE THEREOF
#326PDL-1 antibody, pharmaceutical composition thereof, and uses thereof
#327Immune-modulating compounds
#328COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES
#329Compositions and methods for identification, assessment, prevention, and treatment of melanoma using PD-L1 isoforms
#330CTLA4/PD1 targeted/immunomodulatory fusion proteins
#331MULTIPLE TRANSGENE RECOMBINANT ADENOVIRUS
#332Recombinant oncolytic virus, synthetic DNA sequence, and application thereof
#333Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion
#334Therapeutic and diagnostic methods for cancer
#335METHODS OF TREATING CANCER USING ANTI-PD-L1 ANTIBODIES AND ANTIANDROGENS
#336Feeder cell and method for growing gamma delta T cells by using same
#337Genetically modified non-human animal with human or chimeric PD-L1
#338Intestinal expression of programmed death ligand 1
#339BSL2v2c2-Ig polypeptides
#340Specific bifunctional BY-001 (active composition of homomultimer of chimeric protein pd-L1 / fc-gamma1) down regulates the activation of human immune cells and the use thereof
#341Non-cytotoxic modified cells and use thereof
#342Therapeutic multi-targeting constructs and uses thereof
#343Therapeutic and diagnostic methods for cancer
#344Exosomes for immuno-oncology and anti-inflammatory therapy
#345CD80 extracellular domain polypeptides and their use in cancer treatment
#346CD80 EXTRACELLULAR DOMAIN POLYPEPTIDES AND THEIR USE IN CANCER TREATMENT
#347CD155 variant immunomodulatory proteins and uses thereof
#348Immunotherapy methods using anti-PD-L1 antibodies in combination with EGFR1 targeted-TGF-beta immunomodulatory fusion proteins
#349Variant PD-L1 polypeptides, T-cell modulatory multimeric polypeptides, and methods of use thereof
#350COMPOSITIONS AND METHODS OF CHIMERIC ALLOANTIGEN RECEPTOR T CELLS
#351Methods and compositions for chimeric antigen receptor targeting cancer cells
#352ANTI-PLACENTA-CHONDROITIN-SULFATE CHIMERIC ANTIGEN RECEPTOR AND APPLICATION THEREOF
#353Nucleic acid aptamers
#354CD80 variant immunomodulatory proteins and uses thereof
#355Fusion proteins of PD-1 and 4-1BB
#356T-cell modulatory multimeric polypeptides and methods of use thereof
#357Method for the treatment of malignancies
#358PD-L1 expressing hematopoietic stem cells and uses
#359Subcutaneous Delivery of Adenovirus with Dual Targeting
#360Oncolytic adenovirus encoding a B7 protein or active fragment
#361T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF
#362Eliminating MHC restriction from the T cell receptor as a strategy for immunotherapy
#363Compositions and methods for treating cancer with anti-ROR1 immunotherapy
#364Oncolytic viral delivery of therapeutic polypeptides
#365Immunostimulating vector system
#366Vector co-expressing vaccine and costimulatory molecules
#367MRNA combination therapy for the treatment of cancer
#368Vector co-expressing vaccine and costimulatory molecules
#369Agents and compositions for eliciting an immune response
#370Anti-CD276 chimeric antigen receptors
#371PD-1 and CTLA-4 dual inhibitor peptides
#372Polypeptide
#373PDL-1 antibody, pharmaceutical composition thereof, and uses thereof
#374Polypeptide
#375Ligands of B7H receptor in the treatment of osteopenia and osteoporosis
#376Methods for engineering allogeneic T cell to increase their persistence and/or engraftment into patients
#377SECRETORY TNT CAR CELL IMMUNOTHERAPY
#378High-affinity and soluble PDL-1 molecule
#379B7 FAMILY MEMBER zB7H6 AND RELATED COMPOSITIONS AND METHODS
#380COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES
#381B7-H5, a costimulatory polypeptide
#382Immunomodulatory proteins with tunable affinities
#383Vista modulators for diagnosis and treatment of cancer
#384PD-L1 EXPRESSING HEMATOPOIETIC STEM CELLS AND USES
#385Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
#386Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
#387Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity.
#388Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
#389Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
#390Use of chimeric antigen receptor modified cells to treat cancer
#391Oncolytic adenovirus encoding a B7 protein
#392Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion
#393CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE
#394Epidermal growth factor receptor targeted/immunomodulatory fusion proteins and methods of use for them
#395PSEUDOTYPED ONCOLYTIC VIRAL DELIVERY OF THERAPEUTIC POLYPEPTIDES
#396Novel VISTA-Ig constructs and the use of VISTA-Ig for Treatment of Autoimmune, Allergic and Inflammatory Disorders
#397Isolated peptides derived from the B7 ligand dimer interface and uses thereof
#398Oncolytic adenovirus encoding a B7 protein
#399Compositions and methods for expressing polypeptides on the surface of cells
#400Inhibitors of T-cell activation
#401Anti-PD-L1 antibodies and diagnostic uses thereof
#402Anti-PD-L1 antibodies
#403ICOS ligand variant immunomodulatory proteins and uses thereof
#404Anti-PD-L1 antibodies
#405Method of treating CD155 expressing cancers
#406Oncolytic adenovirus encoding a therapeutic protein or active fragment
#407Targeted/TGF-ßRII fusion proteins and methods for making same
#408High affinity PD-1 agents and methods of use
#409PD-1 MODULATION AND USES THEREOF FOR MODULATING HIV REPLICATION
#410Soluble CD80 as a therapeutic to reverse immune suppression in cancer patients
#411BSL2v2c2-Ig polypeptides
#412Compositions and methods for targeted immunomodulatory antibodies and fusion proteins
#413CD80 extracellular domain polypeptides and their use in cancer treatment
#414CELL BASED ASSAY TO MEASURE THE T-CELL STIMULATING CAPACITY OF ANTI-LAG3 ANTIBODIES AND OTHER AGENTS
#415COMPOSITIONS AND METHODS FOR TARGETING A PATHWAY
#416Fusion protein for treating rejection reaction in transplantation
#417Multi-arm linker for treating rejection reaction in transplantation
#418Oncolytic adenovirus encoding a B7 protein or active fragment
#419Immunotherapy with Binding Agents
#420Compositions and methods for targeted immunomodulatory antibodies and fusion proteins
#421B7-related nucleic acids and polypeptides useful for immunomodulation
#422COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF MELANOMA USING PD-L1 ISOFORMS
#423Enhanced antigen presenting ability of RNA CAR T cells by co-introduction of costimulatory molecules
#424B7X and its derivatives for treating and preventing cardiovascular disease
#425CD86 variants with improved affinity for CTLA-4
#426Vector co-expressing vaccine and costimulatory molecules
#427Anti-CTLA4 antibody-TGF-βRII targeted/immunomodulatory fusion proteins
#428Isolated B7-H4 specific compositions and methods of use thereof
#429Chimeric antigen receptors targeting GPC3 and uses thereof
#430Screening method for inhibitors of binding of zBR7R1 to CD155
#431Methods and materials for treating cancer
#432SYSTEMS AND METHODS FOR ASSESSING MODULATORS OF IMMUNE CHECKPOINTS
#433Method of treating cancer with an EGFR targeted immunomodulatory fusion protein
#434RECEPTORS FOR B7-H4
#435METHODS AND COMPOSITIONS FOR THE INHIBITION OF TRANSPLANT REJECTION
#436B7-H4 fusion proteins and methods of use thereof
#437Methods of modulating immune function
#438ANTI-PD-L1 ANTIBODIES AND DIAGNOSTIC USES THEREOF
#439Agents that modulate immune cell activation and methods of use thereof
#440B7-H1, A NOVEL IMMUNOREGULATORY MOLECULE
#441Soluble CD80 as a therapeutic to reverse immune suppression in cancer patients
#442B7-H5, a costimulatory polypeptide
#443Compositions and methods for targeted immunomodulatory antibodies and fusion proteins
#444B7 family member zB7H6 and related compositions and methods
#445COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES
#446COMPOSITIONS AND METHODS FOR PREVENTING ALLOGENEIC IMMUNE REJECTION
#447Targeted/immunomodulatory fusion proteins and methods for making same
#448Inhibitors of T-cell activation
#449Vista modulators for diagnosis and treatment of cancer
#450B7-H3L cell surface antigen and antibodies that bind thereto
#451Isolated B7-H4 specific compositions and methods of use thereof
#452Isolated B7-H4 specific compositions and methods of use thereof
#453Methods and materials for treating cancer
#454Polypeptides Involved In Immune Response
#455B7-H3 and B7-H4, novel immunoregulatory molecules
#456Polynucleotides encoding BSL2v2c2
#457Polynucleotides encoding BSL2v2c2-Ig
#458Dendritic cell co-stimulatory molecules
#459B7-1-PE40KDEL exotoxin fusion gene-based DNA vaccine and the use thereof
#460B7-H5, a costimulatory polypeptide
#461Soluble CD80 as a therapeutic to reverse immune supression in cancer patients
#462B7L-1 POLYNUCLEOTIDES
#463Porcine CTLA-4 for xenograft-specific immunosuppression
#464Compositions and methods for targeted immunomodulatory antibodies and fusion proteins
#465BSL3 polypeptides
#466METHODS AND PRODUCTS RELATED TO METABOLIC INTERACTIONS IN DISEASE
#467COMPOSITIONS AND METHODS FOR MODULATING LYMPHOCYTE ACTIVITY
#468B7-H4 fusion proteins and methods of use thereof
#469Multimer of extracellular domain of cell surface functional molecule
#470MODULATED PROGRAMMED DEATH LIGAND-1
#471COMPOSITIONS AND METHODS FOR MODULATING LYMPHOCYTE ACTIVITY
#472Methods of modulating immune function
#473COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES
#474COMPOSITIONS AND METHODS FOR MODULATING LYMPHOCYTE ACTIVITY
#475Compositions and methods for modulating lymphocyte activity
#476TH1/TH2 polarizing vaccines
#477Methods and compositions for the inhibition of transplant rejection
#478Immunostimulatory compositions and methods
#479B7-DC variants immunogenic compositions and methods of use thereof
#480Methods for treating inflammation using B7-H4 polypeptides and fragments thereof
#481Compositions of PD-1 antagonists and methods of use
#482Compositions of PD-1 antagonists and methods of use
#483DENDRITIC CELL CO-STIMULATORY MOLECULES
#484DENDRITIC CELL CO-STIMULATORY MOLECULES
#485B7-H1 antibodies and method of use
#486Nucleic acid molecules encoding B7-DC variants
#487Polynucleotides encoding BSL2vcvc-lg
#488Antibody specific for B7-H5, a costimulatory polypeptide
#489Compositions and methods for modulating lymphocyte activity
#490TARGETED COSTIMULATORY POLYPEPTIDES AND METHODS OF USE TO TREAT CANCER
#491COMPOSITIONS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE
#492PD-1 ANTAGONISTS AND METHODS OF USE THEREOF
#493COMPOSITIONS AND METHODS FOR TREATING INFLAMMATION AND AUTO-IMMUNE DISEASES
#494PD-1 ANTAGONISTS AND METHODS FOR TREATING INFECTIOUS DISEASE
#495Receptor modulators
#496B7 family member zB7H6 and related compositions and methods
#497Vector
#498METHODS AND COMPOSITIONS FOR EXPANDING T REGULATORY CELLS
#499Feline CD86 polypeptides and nucleic acids
#500Mutant human CD80 and compositions for and methods of making and using the same
#501Combination cancer immunotherapy with co-stimulatory molecules
#502Combination cancer immunotherapy with co-stimulatory molecules
#503COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES
#504Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
#505Novel co-stimulatory molecules
#506IN VIVO CELL SURFACE ENGINEERING
#507Antibodies that bind B7L-1
#508Immunostimulatory compositions and methods
#509Porcine CTLA-4 for xenograft-specific immunosuppression
#510MOLECULES DESIGNATED B7L-1
#511BSL3 antibodies
#512BSL2v1c2 polypeptides
#513Virus-expressing host costimulation molecules
#514Compositions of PD-1 antagonists and methods of use
#515Use of anti-GL50 antibodies for the downmodulation of an immune response
#516B7-H1 Antibodies
#517Multimer of extracellular domain of cell surface functional molecule
#518B7-H1, a novel immunoregulatory molecule
#519B7-H2 molecules, novel members of the B7 family and uses thereof
#520Human B7 polypeptides
#521Anti-zB7H6 antibody-drug conjugates
#522BSL3 polypeptides
#523B7RP-1 antagonists
#524B7-H3L cell surface antigen and antibodies that bind thereto
#525METHODS FOR INHIBITING AN IMMUNE RESPONSE BY BLOCKING THE GP39/CD40 AND CTLA4/CD28/B7 PATHWAYS AND COMPOSITIONS FOR USE THEREWITH
#526Modified KSA and Uses Thereof
#527COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES
#528Anti-CD40 antibodies capable of blocking B-cell activation
#529Nucleic acids encoding B7-H4, a T cell immunoregulatory molecule
#530Polynucleotides encoding members of the human B lymphocyte activation antigen B7 family and polypeptides encoded thereby
#531B7-DC variants immunogenic compositions and methods of use thereof
#532Recombinant vector expressing multiple costimulatory molecules and uses thereof
#533Methods for treating autoimmune diseases using B7-H4 polypeptides and fragments thereof
#534B7-H3 and B7-H4, Novel Immunoregulatory Molecules
#535Vector
#536B7-Like Molecules and Uses Thereof
#537Method of enhancing a targeted immune response against tumors
#538COMPOSITIONS AND METHODS FOR MODULATING LYMPHOCTE ACTIVITY
#539Ligands and libraries of ligands
#540B7-H5, a costimulatory polypeptide
#541Methods of using B7-DC molecules to induce or enhance an immune response
#542Dendritic cell co-stimulatory molecules
#543COMPOSITIONS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE
#544Methods and products related to metabolic interactions in disease
#545Methods and products related to metabolic interactions in disease
#546B7-H3 and B7-H4, novel immunoregulatory molecules
#547VECTOR SYSTEM
#548Compositions and methods for treating inflammation and auto-immune diseases
#549Novel polypeptides involved in immune response
#550Molecules designated B7L-1
#551Receptor modulators
#552B7S1: an immune modulator
#553TETRAMERIZING POLYPEPTIDES AND METHODS OF USE
#554TETRAMERIZING POLYPEPTIDES AND METHODS OF USE
#555Methods of upmodulating an immune response with non-activating forms of B7-4
#556Immunostimulatory compositions and methods
#557Methods and compositions for expanding T regulatory cells
#558In vivo cell surface engineering
#5597C10 and 16C10 CD80-specific antibodies
#560Nucleic acid molecules encoding B7-1
#561Use of agents that modulate the interaction between PD-1 and its ligands in the downmodulation of immune responses
#562Compositions and methods for modulating immune responses
#563Nucleic acid encoding dendritic cell co-stimulatory molecules
#564Vector
#565Methods of using pNKp30, a member of the B7 family, to modulate the immune system
#566Downregulation of immune response by administering B7RP-2 fusion protein
#567Enduring T cell response
#568Inhibition of T cell activation by butyrophilin 4 or B7-L1
#569Methods for selectively modulating a Th2-type response within a population of activated CD4+ T cells
#570Compositions comprising a first agent which provides a primary activation signal to T cells and a second agent which stimulates an accessory molecule on the surface of T cells
#571Canine B7-1 nucleic acid molecules
#572Feline CTLA-4 nucleic acid and polypeptides
#573Combination cancer immunotherapy with co-stimulatory molecules
#574B7-like molecules and uses thereof
#575Polynucleotides encoding BSL2v1c2-Ig
#576Human B7 polypeptide B7-H3A
#577B7-4 Antibodies and uses therefor
#578Viral vectors and the use of the same for gene therapy
#579Polynucleotides encoding BSL3
#580Immunosuppression
#581Anti-GL50 antibodies
#582Tumor cells with increased immunogenicity and uses therfor
#583Methods for downmodulating immune cells using an antibody to PD-1
#584Methods for treating HIV infected subjects
#585Nucleic acids encoding B7-Like molecules and uses thereof
#586Polynucleotides-encoding B7-related polypeptide, BSL2-L165-35B
#587Nucleic acids encoding B7-H4, a T cell immunoregulatory molecule
#588Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith
#589Method of enhancing a targeted immune response against tumors
#590Anti-CD40 antibodies capable of blocking B-cell activation
#591B7S1: an immune modulator
#592Methods and products related to metabolic interactions in disease
#593Novel co-stimulatory molecules
#594Anti-CD80 antibodies
#595Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor
#596Method for identifying target epitopes of the T cell mediated immune response and for assaying epitope-specific T cells
#597Methods and products related to metabolic interactions in disease
#598Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule
#599Methods and products related to metabolic interactions in disease
#600Vector